Armed with $95m in funding and a former Pfizer drug discovery specialist, Khartis Therapeutics has emerged with the aim of bringing a new treatment for an autoimmune disease that ...

The FDA has granted accelerated approval to BMS' Zenbexus, along with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd), to treat adult multiple myeloma.

The HARMONi-6 trial included patients with locally advanced or metastatic squamous NSCLC, regardless of PD-L1 expression. Credit: Saiful52 / Shutterstock.com. Summit Therapeutics’ partner Akeso has ...

Eli Lilly is suing several US companies that are allegedly selling illegal versions of its weight loss candidate, retatrutide.

Remepy has secured $36m in Series A funds to accelerate its pharmaceutical co-development partnerships and expand its hybrid drug pipeline.

The CRISPR therapy, SNIPR001, was administered to the patient who had developed E. Coli following a single-patient emergency IND.

Infinimmune has raised $75m in Series A financing, helping the biotech advance its atopic dermatitis (AD)-centric pipeline. As part of the round, Infinimmune garnered the interest ...

Epicrispr and Vaderis have secured $90m and $152m, respectively, to take their rare disease drugs to pivotal clinical development.

Mereo BioPharma and Sentynl Therapeutics have signed an option and licence agreement related to the US commercial and worldwide manufacturing rights to alvelestat, a potential oral treatment for ...

The acquisition will bring Nordic Pharma’s rheumatoid arthritis business into Alfasigma’s portfolio. Credit: Stock-Asso / Shutterstock.com. Alfasigma has agreed to purchase Nordic Group, a move aimed ...